Moon H, Luo Y, Chugh D, Zhao L
Front Mol Neurosci. 2024; 17:1399965.
PMID: 39169951
PMC: 11335735.
DOI: 10.3389/fnmol.2024.1399965.
Xia Z, Prescott E, Urbanek A, Wareing H, King M, Olerinyova A
Nat Commun. 2024; 15(1):4695.
PMID: 38824138
PMC: 11144216.
DOI: 10.1038/s41467-024-49028-z.
Zhang M, Zhu Y, Zhu Z
Ibrain. 2024; 10(1):83-92.
PMID: 38682015
PMC: 11045198.
DOI: 10.1002/ibra.12018.
Konings S, Nyberg E, Martinsson I, Torres-Garcia L, Klementieva O, Guimas Almeida C
Life Sci Alliance. 2023; 6(8).
PMID: 37290814
PMC: 10250689.
DOI: 10.26508/lsa.202201887.
Meuret C, Hu Y, Smadi S, Bantugan M, Xian H, Martinez A
Alzheimers Res Ther. 2023; 15(1):96.
PMID: 37221560
PMC: 10204298.
DOI: 10.1186/s13195-023-01239-0.
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
Lennol M, Sanchez-Dominguez I, Cuchillo-Ibanez I, Camporesi E, Brinkmalm G, Alcolea D
Alzheimers Res Ther. 2022; 14(1):161.
PMID: 36324176
PMC: 9628034.
DOI: 10.1186/s13195-022-01108-2.
Apolipoprotein E: Structural Insights and Links to Alzheimer Disease Pathogenesis.
Chen Y, Strickland M, Soranno A, Holtzman D
Neuron. 2020; 109(2):205-221.
PMID: 33176118
PMC: 7931158.
DOI: 10.1016/j.neuron.2020.10.008.
Genealogy of the neurodegenerative diseases based on a meta-analysis of age-stratified incidence data.
Gerovska D, Irizar H, Otaegi D, Ferrer I, de Munain A, Arauzo-Bravo M
Sci Rep. 2020; 10(1):18923.
PMID: 33144621
PMC: 7609593.
DOI: 10.1038/s41598-020-75014-8.
Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology.
Oh S, Kim J, Park S, Lee J
Int J Mol Sci. 2020; 21(3).
PMID: 31991844
PMC: 7037199.
DOI: 10.3390/ijms21030802.
Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities.
Hemonnot A, Hua J, Ulmann L, Hirbec H
Front Aging Neurosci. 2019; 11:233.
PMID: 31543810
PMC: 6730262.
DOI: 10.3389/fnagi.2019.00233.
Higher Level of Mismatch in APOEε4 Carriers for Amyloid-Beta Peptide Alzheimer's Disease Biomarkers in Cerebrospinal Fluid.
Vogelgsang J, Vukovich R, Wedekind D, Wiltfang J
ASN Neuro. 2019; 11:1759091419845524.
PMID: 31104469
PMC: 6535906.
DOI: 10.1177/1759091419845524.
Systemic LPS-induced Aβ-solubilization and clearance in AβPP-transgenic mice is diminished by heparanase overexpression.
Jendresen C, Digre A, Cui H, Zhang X, Vlodavsky I, Li J
Sci Rep. 2019; 9(1):4600.
PMID: 30872722
PMC: 6418119.
DOI: 10.1038/s41598-019-40999-4.
Opposing Roles of apolipoprotein E in aging and neurodegeneration.
Hudry E, Klickstein J, Cannavo C, Jackson R, Muzikansky A, Gandhi S
Life Sci Alliance. 2019; 2(1).
PMID: 30760557
PMC: 6374993.
DOI: 10.26508/lsa.201900325.
A flow cytometry-based assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type.
Kara E, Marks J, Roe A, Commins C, Fan Z, Calvo-Rodriguez M
J Biol Chem. 2018; 293(34):13247-13256.
PMID: 29950521
PMC: 6109911.
DOI: 10.1074/jbc.RA117.001388.
Systemic AA amyloidosis in the red fox (Vulpes vulpes).
Rising A, Cederlund E, Palmberg C, Uhlhorn H, Gaunitz S, Nordling K
Protein Sci. 2017; 26(11):2312-2318.
PMID: 28791746
PMC: 5654853.
DOI: 10.1002/pro.3264.
The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway.
Jendresen C, Arskog V, Daws M, Nilsson L
J Neuroinflammation. 2017; 14(1):59.
PMID: 28320424
PMC: 5360024.
DOI: 10.1186/s12974-017-0835-4.
Is ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?.
Ba M, Kong M, Li X, Ng K, Rosa-Neto P, Gauthier S
Transl Neurodegener. 2016; 5:20.
PMID: 27891223
PMC: 5112745.
DOI: 10.1186/s40035-016-0067-z.
Statins for the prevention of dementia.
McGuinness B, Craig D, Bullock R, Passmore P
Cochrane Database Syst Rev. 2016; (1):CD003160.
PMID: 26727124
PMC: 9346344.
DOI: 10.1002/14651858.CD003160.pub3.
Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease.
Christensen A, Pike C
Front Aging Neurosci. 2015; 7:130.
PMID: 26217222
PMC: 4493396.
DOI: 10.3389/fnagi.2015.00130.
Role of apolipoprotein E in neurodegenerative diseases.
Giau V, Bagyinszky E, An S, Kim S
Neuropsychiatr Dis Treat. 2015; 11:1723-37.
PMID: 26213471
PMC: 4509527.
DOI: 10.2147/NDT.S84266.